In Brief: Bausch & Lomb
This article was originally published in The Gray Sheet
Executive SummaryBausch & Lomb: Senior vice president and global business manager Carl Sassano promoted to corporate executive vice president and president-Bausch & Lomb Vision Care. In addition to his current duties, Sassano will be responsible for worldwide commercial management of Bausch & Lomb's vision care business. Sassano replaces James Kanaley, who plans to retire in the first half of 1997...
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.